Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Douglas L. Jennings"'
Autor:
Brent N. Reed, Robert J. DiDomenico, J. Erin Allender, James C. Coons, Jenna F. Cox, Daniel Johnson, Carrie S. Oliphant, Douglas L. Jennings
Publikováno v:
Journal of Interventional Cardiology, Vol 2019 (2019)
Objectives. To characterize anticoagulation practices with the Impella percutaneous ventricular assist device (pVAD). Background. Managing anticoagulation in patients being supported by the Impella pVAD is made challenging by several unique features
Externí odkaz:
https://doaj.org/article/6526330b72454541a334a629cf3cc1e7
Autor:
Barry Trachtenberg, JENNIFER COWGER, DOUGLAS L. JENNINGS, GILLIAN GRAFTON, RENZO LOYAGA-RENDON, REBECCA COGSWELL, LIVIU KLEIN, PALAK SHAH, MICHAEL KIERNAN, ESTHER VOROVICH
Publikováno v:
Journal of Cardiac Failure. 29:479-502
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c873bca53e0fc6218c96739ee5e62eb
https://doi.org/10.1016/j.cardfail.2023.01.009
https://doi.org/10.1016/j.cardfail.2023.01.009
Autor:
Douglas L Jennings, Bruno Bohn, Amelia Zuver, Duygu Onat, Maureen Gaine, Eugene Royzman, Jonathan Hupf, Danielle Brunjes, Farhana Latif, Susan Restaino, Arthur R Garan, Veli K Topkara, Hiroo Takayama, Koji Takeda, Yoshifumi Naka, Maryjane Farr, Renu Nandakumar, Anne-Catrin Uhlemann, Paolo C Colombo, Ryan T Demmer, Melana Yuzefpolskaya
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0233646 (2020)
IntroductionEffective tacrolimus (TAC) dosing is hampered by complex pharmacokinetics and significant patient variability. The gut microbiome, a key mediator of endotoxemia, inflammation and oxidative stress in advanced heart failure (HF) patients, i
Externí odkaz:
https://doaj.org/article/9df5afc892164e3d81d675cf6aa0e342
Autor:
Sabeena Arora, Joseph Radojevic, Ayyaz Ali, Douglas L. Jennings, Jonathan Hammond, Jason Gluck, Abhishek Jaiswal, William L. Baker, Naga Vaishnavi Gadela, A. Scatola, Oisharya Dasgupta, David A. Baran
Publikováno v:
ASAIO Journal. 68:914-919
With the implementation of the new heart transplant (HT) allocation system, patients requiring biventricular support systems have the highest priority, a shorter waitlist time, and a higher frequency of HT. However, the short-term and long-term outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::254a67332a19c98a4b861ad02ed43bed
https://doi.org/10.1097/mat.0000000000001588
https://doi.org/10.1097/mat.0000000000001588
Autor:
Alberto Pinsino, Matthew R. Carey, Syed Husain, Sumit Mohan, Jai Radhakrishnan, Douglas L. Jennings, Austin S. Nguonly, Annamaria Ladanyi, Lorenzo Braghieri, Koji Takeda, Robert T. Faillace, Gabriel T. Sayer, Nir Uriel, Paolo C. Colombo, Melana Yuzefpolskaya
Publikováno v:
American Journal of Kidney Diseases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c984c4e49ee03738f3da458b1b08612
https://doi.org/10.1053/j.ajkd.2023.03.005
https://doi.org/10.1053/j.ajkd.2023.03.005
Autor:
Naga Vaishnavi Gadela, William L. Baker, Sabeena Arora, Douglas L. Jennings, Jonathan Hammond, Ayyaz Ali, David A. Baran, Kathir Balakumaran, A. Scatola, Jason Gluck, Abhishek Jaiswal, Joseph Radojevic
Publikováno v:
Journal of the American Geriatrics Society. 69:2507-2517
OBJECTIVE To examine if older age (>70 years) should be a relative contraindication for heart transplantation, we evaluated the characteristics and outcomes of patients with age ≥70 years listed for heart transplantation; and whether post-transplan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02b83fb3eecf1a15760080fdcc765b64
https://doi.org/10.1111/jgs.17271
https://doi.org/10.1111/jgs.17271
Autor:
Tara Shertel, Nicholas W. Lange, David M. Salerno, Jessica Hedvat, Douglas L. Jennings, Jason Y. Choe, Robert S. Brown, Marcus R. Pereira
Publikováno v:
Transplantation. 106(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c432f9a48ff7d734c328df63c87a58fb
https://pubmed.ncbi.nlm.nih.gov/35939386
https://pubmed.ncbi.nlm.nih.gov/35939386
Autor:
Lorenzo Braghieri, Douglas L. Jennings, Bruno Bohn, Marlena Habal, Alberto Pinsino, Giulio M. Mondellini, Annamaria Ladanyi, Farhana Latif, Kevin Clerkin, Susan Restaino, Paul Kurlansky, Koji Takeda, Yoshifumi Naka, Ryan T. Demmer, Gabriel T. Sayer, Nir Uriel, Paolo C. Colombo, Melana Yuzefpolskaya
Publikováno v:
PharmacotherapyREFERENCES. 42(9)
Mycophenolate mofetil (MMF) is the gold-standard immunosuppressive agent in heart transplantation (HT), but dose-dependent toxicities (e.g., neutropenia) are frequent. Gut bacteria β-d-glucuronidases (GUS) modulate MMF bioavailability, and changes i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7dee40542b6be7e3bc3971a4cf68ba3
https://pubmed.ncbi.nlm.nih.gov/35979678
https://pubmed.ncbi.nlm.nih.gov/35979678
Autor:
Jessica Hedvat, Nicholas W. Lange, David M. Salerno, Ersilia M. DeFilippis, Danielle Kovac, Heather Corbo, Justin K. Chen, Jason Y. Choe, Jennifer H. Lee, Anastasia Anamisis, Douglas L. Jennings, Giovanna Codispodo, Tara Shertel, Robert S. Brown, Marcus R. Pereira
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsREFERENCES. 22(11)
Treatment outcomes associated with the use of novel COVID-19 therapeutics in solid organ transplant recipients (SOTR) are not well described in the literature. The objective of this analysis was to characterize 30-day hospitalization and other key se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::042b473cee01420bc7d5928c27727bc8
https://pubmed.ncbi.nlm.nih.gov/35801839
https://pubmed.ncbi.nlm.nih.gov/35801839
Autor:
Joseph Sanchez, Melana Yuzefpolskaya, Amit Saha, Yoshifumi Naka, Douglas L. Jennings, Hiroo Takayama, Paolo C. Colombo, Koji Takeda, Paul Kurlansky, Andrea N. Miltiades, Jessica L. Spellman, Yuming Ning
Publikováno v:
The Annals of Thoracic Surgery. 111:800-808
Background Vasoplegia is a frequent complication of left ventricular assist device (LVAD) implantation. We investigated the effectiveness of methylene blue (MB) for vasoplegia in LVAD recipients. Methods Twenty-seven patients received MB for vasopleg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::802e1bb40ae7536e1a328109c3bc5c05
https://doi.org/10.1016/j.athoracsur.2020.05.172
https://doi.org/10.1016/j.athoracsur.2020.05.172